Skip to main content
Premium Trial:

Request an Annual Quote

IntegenX Gets $5M Loan from Square 1 Bank


Square 1 Bank said today that it has provided a $5 million debt facility to sample preparation firm IntegenX.

Based in Pleasanton, Calif., privately held IntegenX integrates advanced fluidics and robotic capabilities to produce sample-to-answer products for DNA-based forensics and human identity testing, next-generation sequencing, biodefense, and molecular diagnostics applications.

Last week, IntegenX announced that it had secured $40 million in Series C financing to accelerate the development of its product pipeline and commercialization of its RapidHit 200 Human Identification System in the US and international markets (PCR Insider, 12/15/2011).

IntegenX also markets the Apollo 324, an automated platform for next-generation sequencing DNA and RNA library preparation; and the GenTegra and GenPlate products for stabilizing DNA, RNA, whole blood, and biological fluids for dry-state, room-temperature storage without degradation.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.